Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Ischemic Heart Disease

  Free Subscription


Articles published in Ann Intern Med

Retrieve available abstracts of 90 articles:
HTML format



Single Articles


    October 2024
  1. WOODRUFF RC, Kaholokula JK, Riley L, Tong X, et al
    Cardiovascular Disease Mortality Among Native Hawaiian and Pacific Islander Adults Aged 35 Years or Older, 2018 to 2022.
    Ann Intern Med. 2024 Oct 15. doi: 10.7326/M24-0801.
    PubMed     Abstract available


  2. FITCH KV, Zanni MV, Manne-Goehler J, Diggs MR, et al
    Diabetes Risk Factors in People With HIV Receiving Pitavastatin Versus Placebo for Cardiovascular Disease Prevention : A Randomized Trial.
    Ann Intern Med. 2024 Oct 8. doi: 10.7326/ANNALS-24-00944.
    PubMed     Abstract available


  3. PORTELA GT, Carson JL, Swanson SA, Alexander JH, et al
    Effect of Four Hemoglobin Transfusion Threshold Strategies in Patients With Acute Myocardial Infarction and Anemia : A Target Trial Emulation Using MINT Trial Data.
    Ann Intern Med. 2024 Oct 1. doi: 10.7326/M24-0571.
    PubMed     Abstract available


  4. BLOCH EM, Tobian AAR
    Relaxing Transfusion Thresholds for Patients With Myocardial Infarction: Findings From the MINT Trial.
    Ann Intern Med. 2024 Oct 1. doi: 10.7326/M24-0895.
    PubMed    


  5. SHARMA M, Srivastva A
    In ischemic stroke treated within 4.5 h, reteplase vs. alteplase increased excellent functional outcome at 90 d.
    Ann Intern Med. 2024 Oct 1. doi: 10.7326/ANNALS-24-02228.
    PubMed     Abstract available


    September 2024
  6. SEE C, Mooghali M, Dhruva SS, Ross JS, et al
    Class I Recalls of Cardiovascular Devices Between 2013 and 2022 : A Cross-Sectional Analysis.
    Ann Intern Med. 2024 Sep 17. doi: 10.7326/ANNALS-24-00724.
    PubMed     Abstract available


  7. MINHAS AMK, Virani SS, Michos ED, Nambi V, et al
    Comparing Cardiovascular Risk Classification of U.S. Adults According to Pooled Cohort Equations and PREVENT Equations: Cross-Sectional Analysis of the National Health and Nutrition Examination Survey.
    Ann Intern Med. 2024 Sep 3. doi: 10.7326/ANNALS-24-00074.
    PubMed    


  8. FATH AR, Elgendy IY
    After ACS, telemedicine-based care with remote patient monitoring vs. usual care reduced hospital readmissions at 6 mo.
    Ann Intern Med. 2024;177:JC105.
    PubMed     Abstract available


  9. MUKHERJEE D
    In patients with NSTE-ACS and previous CABG, routine invasive vs. conservative management does not improve outcomes.
    Ann Intern Med. 2024;177:JC104.
    PubMed     Abstract available


    August 2024
  10. CHAITOFF A, Bendicksen L, Feldman WB, Zheutlin AR, et al
    Estimating New Eligibility and Maximum Costs of Expanded Medicare Coverage of Semaglutide for Cardiovascular Risk Prevention.
    Ann Intern Med. 2024 Aug 27. doi: 10.7326/ANNALS-24-00308.
    PubMed    


  11. ANDERSON TS, Yeh RW, Herzig SJ, Marcantonio ER, et al
    Trends and Disparities in Ambulatory Follow-Up After Cardiovascular Hospitalizations : A Retrospective Cohort Study.
    Ann Intern Med. 2024 Aug 6. doi: 10.7326/M23-3475.
    PubMed     Abstract available


  12. CLIFFORD C, Yan AT
    After PCI and 1 mo of DAPT for ACS, ticagrelor alone vs. continued DAPT for 11 mo reduced bleeding without increasing MACCE.
    Ann Intern Med. 2024;177:JC86.
    PubMed     Abstract available


  13. SULEIMAN B, Granger CB
    In MI with preserved LVEF, long-term beta-blocker use vs. no use did not reduce all-cause death or MI at 3.5 y.
    Ann Intern Med. 2024;177:JC88.
    PubMed     Abstract available


    July 2024
  14. KEPPEL S, Borzak S
    In adults with AMI who are at risk for HF, empagliflozin did not reduce a composite of first HF hospitalization or all-cause death at 18 mo.
    Ann Intern Med. 2024;177:JC74.
    PubMed     Abstract available


    June 2024
  15. GUPTA M, Gulati S, Nasir K, Sarraju A, et al
    Aspirin Use Prevalence for Cardiovascular Disease Prevention Among U.S. Adults From 2012 to 2021.
    Ann Intern Med. 2024 Jun 25. doi: 10.7326/M24-0427.
    PubMed    


  16. GUALLAR E, Bravo PE, Ferrari VA
    Feeling the Heat: Cardiovascular Consequences of Heat Exposure Under Controlled Experimental Conditions.
    Ann Intern Med. 2024 Jun 11. doi: 10.7326/M24-0882.
    PubMed    


  17. BARRY H, Iglesies-Grau J, Chaseling GK, Paul J, et al
    The Effect of Heat Exposure on Myocardial Blood Flow and Cardiovascular Function.
    Ann Intern Med. 2024 Jun 11. doi: 10.7326/M24-3504.
    PubMed     Abstract available



  18. Correction: Diagnostic Strategies for the Assessment of Suspected Stable Coronary Artery Disease: A Systematic Review and Meta-analysis.
    Ann Intern Med. 2024 Jun 4. doi: 10.7326/ANNALS-24-00550.
    PubMed    


  19. CHIA JE, Mukherjee D
    After stent implantation for ACS, ticagrelor monotherapy after <1 mo of DAPT vs. 12 mo of DAPT improved 1-y net clinical benefit.
    Ann Intern Med. 2024;177:JC64.
    PubMed     Abstract available


    May 2024

  20. Annals Video Summary - Associations of Testosterone and Related Hormones With All-Cause and Cardiovascular Mortality and Incident Cardiovascular Disease in Men.
    Ann Intern Med. 2024 May 14:eM240479. doi: 10.7326/M24-0479.
    PubMed    


  21. YEAP BB, Marriott RJ, Dwivedi G, Adams RJ, et al
    Associations of Testosterone and Related Hormones With All-Cause and Cardiovascular Mortality and Incident Cardiovascular Disease in Men : Individual Participant Data Meta-analyses.
    Ann Intern Med. 2024 May 14. doi: 10.7326/M23-2781.
    PubMed     Abstract available


  22. BATES ER
    In patients with type 2 diabetes and recent MI, colchicine reduced a composite CV outcome at 23 mo.
    Ann Intern Med. 2024 May 7. doi: 10.7326/J24-0026.
    PubMed     Abstract available


  23. WEITZ HH, Merli GJ, Carson JL
    Web Exclusive. Annals Consult Guys - Acute Coronary Syndrome and Anemia: When to Transfuse?
    Ann Intern Med. 2024;177:eW240002.
    PubMed    


    April 2024
  24. YEN FS, Hwu CM, Liu JS, Wu YL, et al
    Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Dialysis and Cardiovascular Disease in Patients With Stage 5 Chronic Kidney Disease.
    Ann Intern Med. 2024 Apr 30. doi: 10.7326/M23-1874.
    PubMed     Abstract available


  25. GREENWOOD H, Barnes K, Clark J, Ball L, et al
    Long-Term Effect of Salt Substitution for Cardiovascular Outcomes : A Systematic Review and Meta-Analysis.
    Ann Intern Med. 2024 Apr 9. doi: 10.7326/M23-2626.
    PubMed     Abstract available



  26. Annals Video Summary - Long-Term Effect of Salt Substitution for Cardiovascular Outcomes: A Systematic Review and Meta-analysis.
    Ann Intern Med. 2024 Apr 9:eM240208. doi: 10.7326/M24-0208.
    PubMed    


  27. KIRSCHNER J, Hunter B
    In suspected ACS, hs-cTnI- vs. c-cTnI-guided care was associated with improved outcomes at 5 y in certain subgroups.
    Ann Intern Med. 2024;177:JC41.
    PubMed     Abstract available


    March 2024
  28. WEISS J, Raghu VK, Paruchuri K, Zinzuwadia A, et al
    Deep Learning to Estimate Cardiovascular Risk From Chest Radiographs : A Risk Prediction Study.
    Ann Intern Med. 2024 Mar 26. doi: 10.7326/M23-1898.
    PubMed     Abstract available


  29. MUKHERJEE D
    In acute MI and anemia, restrictive vs. liberal transfusion did not differ for a composite of recurrent MI or death at 30 d.
    Ann Intern Med. 2024 Mar 5. doi: 10.7326/J24-0010.
    PubMed     Abstract available


  30. BAVISHI C
    In adults with stable angina, PCI vs. a placebo procedure reduced angina symptoms at 12 wk.
    Ann Intern Med. 2024;177:JC28.
    PubMed     Abstract available


  31. YONIS H, Granger CB
    In adults aged >/=80 y with NSTE-ACS, an invasive vs. conservative strategy improved outcomes at a median 5.3 y.
    Ann Intern Med. 2024;177:JC27.
    PubMed     Abstract available


    February 2024
  32. WEITZ HH, Merli GJ
    Web Exclusive. Annals Consult Guys - Reversals of Care Started After a Myocardial Infarction.
    Ann Intern Med. 2024;177:eW230013.
    PubMed    


    January 2024
  33. CENTOR RM, Jackevicius CA
    Annals On Call - Low-Cost Generic Cardiovascular Drugs.
    Ann Intern Med. 2024 Jan 2:eA230001. doi: 10.7326/A23-0001.
    PubMed    


    December 2023
  34. SUD M, Sivaswamy A, Austin PC, Anderson TJ, et al
    Development and Validation of the CANHEART Population-Based Laboratory Prediction Models for Atherosclerotic Cardiovascular Disease.
    Ann Intern Med. 2023 Dec 12. doi: 10.7326/M23-1345.
    PubMed     Abstract available


  35. KIM CJ, Sussman JB, Mukamal KJ, Eades M, et al
    Trends in Primary Prevention Statin Use by Cardiovascular Risk Score From 1999 to 2018: A Repeated Cross-Sectional Study.
    Ann Intern Med. 2023 Dec 5. doi: 10.7326/M23-1915.
    PubMed    


  36. GLICK M
    Annals Graphic Medicine - The Heart Attack.
    Ann Intern Med. 2023;176:eG220077.
    PubMed    


  37. MORENO R
    In acute MI complicated by cardiogenic shock, ECLS did not reduce 30-d all-cause mortality.
    Ann Intern Med. 2023;176:JC135.
    PubMed     Abstract available


    November 2023
  38. LIU M, Aggarwal R, Zheng Z, Yeh RW, et al
    Cardiovascular Health of Middle-Aged U.S. Adults by Income Level, 1999 to March 2020 : A Serial Cross-Sectional Study.
    Ann Intern Med. 2023 Nov 21. doi: 10.7326/M23-2109.
    PubMed     Abstract available


    October 2023
  39. BUDOFF MJ, Nasir K, Blaha MJ
    Subclinical Coronary Atherosclerosis and Risk for Myocardial Infarction in a Danish Cohort.
    Ann Intern Med. 2023;176:eL230262.
    PubMed    


  40. KOFOED KF, Fuchs A, Kober LV
    Subclinical Coronary Atherosclerosis and Risk for Myocardial Infarction in a Danish Cohort.
    Ann Intern Med. 2023;176:eL230263.
    PubMed    


    September 2023

  41. Blood Pressure Level in Late Adolescence and Risk for Cardiovascular Events.
    Ann Intern Med. 2023 Sep 26. doi: 10.7326/P23-0007.
    PubMed    


  42. RIETZ H, Pennlert J, Nordstrom P, Brunstrom M, et al
    Blood Pressure Level in Late Adolescence and Risk for Cardiovascular Events : A Cohort Study.
    Ann Intern Med. 2023 Sep 26. doi: 10.7326/M23-0112.
    PubMed     Abstract available


  43. TON IT, Moon J, Sengul A, Mody FV, et al
    Evidence-Based Cardiovascular Disease Medicines' Availability in Low-Cost Generic Drug Programs in the United States : A Cross-Sectional Study.
    Ann Intern Med. 2023 Sep 5. doi: 10.7326/M23-0287.
    PubMed     Abstract available


  44. WEITZ HH, Merli GJ
    Web Exclusive. Annals Consult Guys - Spontaneous Coronary Artery Dissection.
    Ann Intern Med. 2023;176:eW220022.
    PubMed    


    August 2023
  45. WINCHESTER DE, Keating FK, Patel KK, Shah NR, et al
    The Medicare Appropriate Use Criteria Program: A Review of Recommendations for Testing in Coronary Artery Disease.
    Ann Intern Med. 2023 Aug 22. doi: 10.7326/M23-1011.
    PubMed     Abstract available


  46. HE J, Bundy JD, Geng S, Tian L, et al
    Social, Behavioral, and Metabolic Risk Factors and Racial Disparities in Cardiovascular Disease Mortality in U.S. Adults : An Observational Study.
    Ann Intern Med. 2023 Aug 15. doi: 10.7326/M23-0507.
    PubMed     Abstract available


    July 2023
  47. FRANK DA, Johnson AE, Hausmann LRM, Gellad WF, et al
    Disparities in Guideline-Recommended Statin Use for Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and Gender : A Nationally Representative Cross-Sectional Analysis of Adults in the United States.
    Ann Intern Med. 2023 Jul 25. doi: 10.7326/M23-0720.
    PubMed     Abstract available


  48. MCCORMICK N, Yokose C, Wei J, Lu N, et al
    Comparative Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors for Recurrent Gout Flares and Gout-Primary Emergency Department Visits and Hospitalizations : A General Population Cohort Study.
    Ann Intern Med. 2023 Jul 25. doi: 10.7326/M23-0724.
    PubMed     Abstract available



  49. Correction: Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease.
    Ann Intern Med. 2023 Jul 18. doi: 10.7326/L23-0249.
    PubMed    


  50. KESARWANI M
    In ACS with multivessel CAD, immediate vs. staged complete revascularization was noninferior for a composite outcome at 1 y.
    Ann Intern Med. 2023;176:JC76.
    PubMed     Abstract available


  51. COLIVICCHI F
    In CAD, treat-to-target statins were noninferior to high-intensity statins for a composite clinical outcome.
    Ann Intern Med. 2023;176:JC74.
    PubMed     Abstract available


    June 2023
  52. CENTOR RM, Kofoed KF
    Annals On Call - Subclinical Coronary Atherosclerosis.
    Ann Intern Med. 2023 Jun 6:eA220011. doi: 10.7326/A22-0011.
    PubMed    


  53. ZITO A, Galli M, Biondi-Zoccai G, Abbate A, et al
    Diagnostic Strategies for the Assessment of Suspected Stable Coronary Artery Disease : A Systematic Review and Meta-analysis.
    Ann Intern Med. 2023 Jun 6. doi: 10.7326/M23-0231.
    PubMed     Abstract available



  54. Annals Video Summary - Diagnostic Strategies for the Assessment of Suspected Stable Coronary Artery Disease.
    Ann Intern Med. 2023 Jun 6:eM231067. doi: 10.7326/M23-1067.
    PubMed    


    May 2023
  55. RICHARDSON TL JR, Halvorson AE, Hackstadt AJ, Hung AM, et al
    Primary Occurrence of Cardiovascular Events After Adding Sodium-Glucose Cotransporter-2 Inhibitors or Glucagon-like Peptide-1 Receptor Agonists Compared With Dipeptidyl Peptidase-4 Inhibitors: A Cohort Study in Veterans With Diabetes.
    Ann Intern Med. 2023 May 9. doi: 10.7326/M22-2751.
    PubMed     Abstract available


    April 2023
  56. OSERAN AS, Wadhera RK, Orav EJ, Figueroa JF, et al
    Effect of Medicare Advantage on Hospital Readmission and Mortality Rankings.
    Ann Intern Med. 2023;176:480-488.
    PubMed     Abstract available


    March 2023
  57. FUCHS A, Kuhl JT, Sigvardsen PE, Afzal S, et al
    Subclinical Coronary Atherosclerosis and Risk for Myocardial Infarction in a Danish Cohort : A Prospective Observational Cohort Study.
    Ann Intern Med. 2023 Mar 28. doi: 10.7326/M22-3027.
    PubMed     Abstract available


  58. MCDERMOTT M, Newby DE
    Contemporary Natural History of Coronary Artery Disease.
    Ann Intern Med. 2023 Mar 28. doi: 10.7326/M23-0533.
    PubMed    


    January 2023
  59. WEITZ HH, Merli GJ
    Annals Consult Guys - Care of a Patient With Left Ventricular Thrombus.
    Ann Intern Med. 2023;176:eW220014.
    PubMed    


    December 2022
  60. SHIN H, Schneeweiss S, Glynn RJ, Patorno E, et al
    Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors Versus Metformin.
    Ann Intern Med. 2022;175:W155.
    PubMed    


  61. QIU M
    Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors Versus Metformin.
    Ann Intern Med. 2022;175:W155.
    PubMed    


    November 2022
  62. FERGUSON E, Lang E
    In acute ischemic stroke, early IV tenecteplase was noninferior to alteplase for excellent functional outcome.
    Ann Intern Med. 2022 Nov 1. doi: 10.7326/J22-0090.
    PubMed     Abstract available


    October 2022
  63. CAVALLI G, Leong D
    Adult survivors of a first primary invasive cancer had increased risk for cardiovascular disease.
    Ann Intern Med. 2022 Oct 4. doi: 10.7326/J22-0079.
    PubMed     Abstract available


    September 2022
  64. CHEW DS, Whitelaw S, Vaduganathan M, Mark DB, et al
    Patient-Reported Outcomes Measures in Cardiovascular Disease: An Evidence Map of the Psychometric Properties of Health Status Instruments.
    Ann Intern Med. 2022 Sep 20. doi: 10.7326/M22-2234.
    PubMed     Abstract available


    August 2022
  65. INOUE-CHOI M, Ramirez Y, Cornelis MC, Berrington de Gonzalez A, et al
    Tea Consumption and All-Cause and Cause-Specific Mortality in the UK Biobank : A Prospective Cohort Study.
    Ann Intern Med. 2022 Aug 30. doi: 10.7326/M22-0041.
    PubMed     Abstract available


  66. BOTTON J, Jabagi MJ, Bertrand M, Baricault B, et al
    Risk for Myocardial Infarction, Stroke, and Pulmonary Embolism Following COVID-19 Vaccines in Adults Younger Than 75 Years in France.
    Ann Intern Med. 2022 Aug 23. doi: 10.7326/M22-0988.
    PubMed     Abstract available


    July 2022
  67. KIRSCHNER JM, Hunter BR
    In intermediate-risk stable chest pain, treatment guided by initial CT vs. ICA did not differ for MACE at 3.5 y.
    Ann Intern Med. 2022 Jul 5. doi: 10.7326/J22-0047.
    PubMed     Abstract available


    June 2022
  68. SMETANA GW, Benson MD, Juraschek SP, Burns RB, et al
    Would You Recommend a Statin to This Patient for Primary Prevention of Cardiovascular Disease? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
    Ann Intern Med. 2022 Jun 14. doi: 10.7326/M22-0908.
    PubMed     Abstract available


    May 2022
  69. SHIN H, Schneeweiss S, Glynn RJ, Patorno E, et al
    Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors Versus Metformin : A Cohort Study.
    Ann Intern Med. 2022 May 24. doi: 10.7326/M21-4012.
    PubMed     Abstract available



  70. Summary for Patients: Risk for Heart Attack After Eye Procedures.
    Ann Intern Med. 2022;175:I22.
    PubMed    


    April 2022
  71. HOLT A, Blanche P, Jensen AKG, Nouhravesh N, et al
    Adverse Events Associated With Coprescription of Phosphodiesterase Type 5 Inhibitors and Oral Organic Nitrates in Male Patients With Ischemic Heart Disease : A Case-Crossover Study.
    Ann Intern Med. 2022 Apr 19. doi: 10.7326/M21-3445.
    PubMed     Abstract available



  72. Summary for Patients: Risk for Unwanted Outcomes in Men Prescribed Both Drugs for Erectile Dysfunction and Nitrates for Angina.
    Ann Intern Med. 2022 Apr 19. doi: 10.7326/P22-0006.
    PubMed    


    March 2022
  73. SEN A, Gemes K, Stalhammar G, Svensen C, et al
    Risk for Acute Myocardial Infarction After Ophthalmologic Procedures.
    Ann Intern Med. 2022 Mar 22. doi: 10.7326/M20-6618.
    PubMed     Abstract available


  74. MURPHY E, McEvoy JW
    Does Stopping Aspirin Differ Fundamentally From Not Starting Aspirin in the Primary Prevention of Cardiovascular Disease Among Older Adults?
    Ann Intern Med. 2022 Mar 15. doi: 10.7326/M22-0550.
    PubMed    


  75. SILVESTRI EG, Borzak S
    In patients with MI or high-risk coronary disease, influenza vaccination reduced CV events at 12 mo.
    Ann Intern Med. 2022 Mar 1. doi: 10.7326/J22-0006.
    PubMed     Abstract available


  76. BACH RG
    DAPT de-escalation from ticagrelor to clopidogrel 1 mo after PCI for acute MI reduced net clinical events at 1 y.
    Ann Intern Med. 2022;175:JC27.
    PubMed     Abstract available


    February 2022
  77. LARDARO T, Hunter BR
    In suspected or provisionally diagnosed ACS, early CTCA did not reduce mortality or nonfatal MI at 1 y.
    Ann Intern Med. 2022;175:JC20.
    PubMed     Abstract available


    January 2022
  78. PATORNO E, Htoo PT, Everett BM, Kim SC, et al
    Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease.
    Ann Intern Med. 2022;175:W4.
    PubMed    


  79. PATORNO E, Htoo PT, Glynn RJ, Schneeweiss S, et al
    Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease.
    Ann Intern Med. 2022;175:W4-W5.
    PubMed    


  80. BEPO L, Makam AN, Nguyen OK
    Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease.
    Ann Intern Med. 2022;175:W3.
    PubMed    


  81. QIU M
    Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease.
    Ann Intern Med. 2022;175:W3-W4.
    PubMed    


    December 2021
  82. YEAP BB, Marriott RJ, Antonio L, Raj S, et al
    Associations of Serum Testosterone and Sex Hormone-Binding Globulin With Incident Cardiovascular Events in Middle-Aged to Older Men.
    Ann Intern Med. 2021 Dec 28. doi: 10.7326/M21-0551.
    PubMed     Abstract available


  83. ZHAO D, Guallar E
    Testosterone and Cardiovascular Disease in Men.
    Ann Intern Med. 2021 Dec 28. doi: 10.7326/M21-4777.
    PubMed    


  84. KANNER L, Glatt AE
    Patients with COVID-19 had increased risk for acute MI and ischemic stroke at 14 d vs. matched controls.
    Ann Intern Med. 2021 Dec 7. doi: 10.7326/ACPJ202112210.
    PubMed     Abstract available


  85. CENTOR RM, Patorno E
    Annals On Call - SGLT2 Versus GLP1 for Cardiovascular Prevention.
    Ann Intern Med. 2021;174:OC1.
    PubMed    


  86. MURRAY H, Petrie C
    In suspected ACS, an unmasked 0/1-h vs. masked 0/3-h hs-cTnT protocol did not differ for death or MI at 1 y.
    Ann Intern Med. 2021;174:JC139.
    PubMed     Abstract available


  87. FAWZY AM, Lip GYH
    In ACS, de-escalation of DAPT reduces bleeding and does not increase ischemic events vs. other DAPT strategies.
    Ann Intern Med. 2021;174:JC138.
    PubMed     Abstract available


    November 2021
  88. CHIANG CH, Chiang CH, Pickering JW, Stoyanov KM, et al
    Performance of the European Society of Cardiology 0/1-Hour, 0/2-Hour, and 0/3-Hour Algorithms for Rapid Triage of Acute Myocardial Infarction : An International Collaborative Meta-analysis.
    Ann Intern Med. 2021 Nov 23. doi: 10.7326/M21-1499.
    PubMed     Abstract available


    October 2021
  89. BURNS RB, Pignone M, Michos ED, Kanjee Z, et al
    Would You Recommend Aspirin to This Patient for Primary Prevention of Atherosclerotic Cardiovascular Disease? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
    Ann Intern Med. 2021 Oct 12. doi: 10.7326/M21-2596.
    PubMed     Abstract available


    September 2021
  90. PATORNO E, Htoo PT, Glynn RJ, Schneeweiss S, et al
    Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease.
    Ann Intern Med. 2021 Sep 28. doi: 10.7326/M21-0893.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.